Objectives-The purpose of this study was to investigate the correlation between flow-mediated dilatation of the brachial artery and serum endothelial biomarkers and to discuss the feasibility of sonographic evaluation of acute endothelial injury during cardiopulmonary bypass (CPB) surgery.
T he endothelium is a thin monolayer of cells that covers the inner lumen of vascular beds throughout the body. The optimally placed healthy endothelium can respond to physical and chemical signals by producing a wide range of factors that regulate vascular tone, smooth muscle cell proliferation, and vessel wall inflammation. It is indispensable for the regulation of vascular tone and the maintenance of vascular homeostasis. 1 However, cardiopulmonary bypass (CPB) surgery, unlike any other normal operation, could cause serious damage to multiple organs, 2 especially injury to the vascular endothelium. [3] [4] [5] Research has shown that endothelial dysfunction could induce hemodynamic instability after CPB and lead to adverse cardiovascular events. 6, 7 Therefore, it is necessary to evaluate endothelial function during the CPB process for a good recovery.
At present, endothelial function may be examined by two main approaches in clinical practice. The primary method is to quantify the laboratory markers associated with endothelial-released substances in plasma, such as nitric oxide (NO), endothelin-1 (ET-1), and von Willebrand factor (vWF). Both NO and ET-1 produced by endothelium play pivotal roles in the maintenance of vascular tone and reactivity. von Willebrand factor is a multimeric glycoprotein that appears to mediate platelet aggregation and adhesion. Numerous clinical and experimental studies have shown that changes in endothelial biomarker levels can reflect damage to the endothelium or endothelial dysfunction. 8 Because it is a nonspecific, 9 invasive, non-real-time measurement and easily affected by other factors, such as drug use, this method has not been widely accepted in clinical practice. Sonography, which is characterized by its noninvasive nature, simple manipulation, and repeatable accuracy and can assess the percentage of change in the brachial artery size during flow-mediated dilatation to reflect endothelial function, has recently been adopted. 10, 11 Sonographic measurement of brachial artery flow-mediated dilatation was reported to detect endothelial dysfunction early and can be used as an independent predictor of cardiovascular complications. [12] [13] [14] However, this method is more frequently applied to chronic disease, such as hypertension 15, 16 and atherosclerosis. 11, 14 Little is known about whether sonographic measurement of brachial artery flow-mediated dilatation can be used to evaluate acute injury to the vascular endothelium in CPB surgery. Therefore, given the current method of assessing endothelial function (eg, biomarkers), a less-invasive and realtime method (eg, sonography) would be much better for detecting acute endothelial injury during the perioperative period of cardiac surgery, and we thought that determining a correlation between the two would be a valuable study to perform.
Materials and Methods
The study was reviewed and approved by the Ethics Committee of our institution; all patients provided written informed consent. A total of 27 patients with CPB cardiac surgery were recruited for the study. Patients who had congestive heart failure were excluded from the study (New York Heart Association class IV), as were those who were classified as American Society of Anesthesiologists physical status V, those who had emergency surgery, and those who could not give consent to participate. General anesthesia was induced with intravenous etomidate (0.2 mg/kg), midazolam (0.4 mg/kg), sufentanil (2 lg/kg), and vecuronium (0.1 mg/kg) and maintained with sevoflurane, propofol, and vecuronium. Mechanical ventilation was performed to maintain the partial oxygen pressure at 33.3 to 40.0 kPa and partial carbon dioxide pressure at nearly 5.3 kPa. Intraoperative monitoring included end-tidal carbon dioxide pressure, electrocardiography, pulse oximetry, esophageal and rectal temperatures, arterial blood gases, direct arterial blood pressure, central venous pressure, and, in most patients, pulmonary artery pressure. Figure 1 illustrates the experimental protocols.
Patients With CPB After median sternotomy and systemic heparinization (heparin, 400 IU/kg), aortic artery cannulation, and bicaval cannulation were performed, CPB was initiated Figure 1 . In all patients, blood samples and flow-mediated dilatation were taken from T1 to T10.
after confirming the adequate activated clotting time. The surgical procedure included coronary artery bypass grafting, valve replacement, valvuloplasty, and other necessary procedures. During the surgical period, the patient's core temperature, including ischemic regions such as the lung and heart, was kept constant at 328C during CPB. Arterial blood samples were taken to measure of ET-1, NO, and vWF, while the percentage of change in the size of brachial artery flow-mediated dilatation was measured by high-resolution sonography, before surgery (T1), 5 minutes after tracheal intubation (T2), 5 minutes after sternotomy (T3), 30 minutes after the start of CPB (T4), 5 minutes after aortic declamping (T5), 5 minutes after CPB (T6), 1 hour after surgery (T7), 1 day after surgery (T8), 3 days after surgery (T9), and 5 days after surgery (T10; Figure 1 ).
Measurement of ET-1, NO, and vWF Concentrations in Blood Plasma
Concentrations of ET-1, NO, and vWF were determined directly in plasma by an enzyme-linked immunosorbent assay. These kits use horseradish peroxidase-conjugated monoclonal antibodies against human ET-1, NO, and vWF (Shanghai Westang Co, Shanghai, China).
Sonographic Measurement of Brachial Artery Flow-Mediated Dilatation
Assessment of flow-mediated dilatation was performed according to the method described in Figure 2 . The examinations were conducted by the same examiner throughout the study. The diameters of the arterial images were obtained on an ultrasound machine (7.5-MHz linear array; SonoSite, Inc, Bothell, WA). Machine operating parameters were kept constant during each study. The right brachial artery was scanned over a longitudinal section 3 to 5 cm above the right elbow. Depth and gain settings were optimized to identify the lumento-vessel wall interface. When an adequate image was obtained, the transducer was kept in the same position throughout the measurement by using a fixed support, and the base diameter value (D1) was measured in 1 minute. A pneumatic tourniquet placed around the upper arm to the target artery was inflated to a pressure of 250 mm Hg, and inflation was held for 5 minutes. Increased flow was then induced by sudden cuff deflation. A second scan was performed continuously for 60 seconds before and 140 seconds after cuff deflation. The diameter of the brachial artery was measured at a fixed distance. The mean diameter was calculated from 3 cardiac cycles synchronized with the R-wave peaks on the electrocardiogram. All measurements were made at end diastole to avoid possible errors resulting from variable arterial compliance. The maximal vasodilatation value (D2) was observed from 40 to 140 seconds after cuff release. The diameter change caused by flow-mediated dilatation was expressed as the percentage of change relative to that at the initial resting scan. The percentage of flow-mediated dilatation was computed by the following formula: flow-mediated dilatation (%) 5 (D22D1)/D1 3 100%.
Statistical Analysis
Normally distributed data (evaluated by KolmogorovSmirnov tests) are presented as mean 6 SD, and nonnormally distributed data are presented as median (interquartile range). Results from statistical tests were regarded as significant at P < .05. For repeated assessments of normally distributed data, comparisons were made by repeated-measures analysis of variance. Post hoc comparisons with T1 used a Bonferroni correction; local P < .01 was regarded as significant, thus maintaining a global a level of .05. For non-normally distributed data, comparisons were made by analysis of variance on ranks for multiple comparisons and Wilcoxon tests as appropriate. Correlations between variables were evaluated by Spearman rank correlation coefficients.
Results

Clinical Characteristics
The patient characteristics, demographic information, and baseline data are listed in Table 1 . Continuous variables are presented as mean 6 SD for normally distributed variables and as median (interquartile range) for variables with a skewed distribution. Discrete variables are described as relative percent (absolute) frequencies. CABG indicates coronary artery bypass grafting; HDL, high-density lipoprotein; LDL, low-density lipoprotein; and PAP, pulmonary artery pressure. 
Plasma Concentrations of ET-1, NO, and vWF Increase Multifold During the Period of CPB
Basal values of ET-1, NO, and vWF in the patients in this study were medians of 46.71 (26.84-64.14) pg/mL, 19.46 (11.09-26.04) lM, and 11.95 (6.93-11.84) mU/ mL, respectively. Figure 3 illustrates the ratio changes, compared with the base values (T1), in ET-1, NO, and vWF concentrations in blood plasma of patients undergoing cardiac surgery. Both NO and vWF showed changes first at 5 minutes after tracheal intubation (T2), whereas ET-1 showed changes at 5 minutes after sternotomy (T3). The median vWF blood plasma concentration increased 3-fold at 30 minutes after the start of CPB (T4). Meanwhile, 5 minutes after aortic declamping (T5), 3-and 2-fold increases occurred in the median levels of ET-1 and NO, respectively. ET-1 concentrations returned to the basal level as soon as 1 day after surgery (T8); moreover, both NO and vWF concentrations did not return to basal levels at 5 days after surgery. All data were corrected for hemodilution (Figure 3 ).
The Percentage of Change in the Size of Brachial Artery Flow-Mediated Dilatation Decreases More During the Period of CPB
The basal percentage of change in brachial artery flowmediated dilatation detected by high-resolution sonography had a median of 12.68% (6.38%-14.75%). Figure 4 illustrates the ratio change in the percentage of brachial artery flow-mediated dilatation after cardiac surgery compared with the base value (T1). The change in the percentage of flow-mediated dilatation was first detected at 5 minutes after tracheal intubation (T2), whereas nearly 3-fold decreases occurred in the medium level of the percentage at 30 minutes after the start of CPB (T4). Moreover, the percentage of flow-mediated dilatation returned to the basal level at 5 days after surgery.
Correlation Between the Percentage of Change in the Size of Brachial Artery Flow-Mediated Dilatation and the Plasma VWF Concentration
The correlations between the percentages of change in the size of brachial artery flow-mediated dilatation and plasma endothelial related biomarkers are shown in Table 2 . There was a significant negative correlation between the percentage of change in the size of brachial artery flow-mediated dilatation and the plasma vWF plasma, whereas no other correlation was evident.
Discussion
To the best of our knowledge, this study is the only quantitative evaluation to access brachial artery flowmediated dilatation during CPB in humans. The principle result of this study was that sonographic measurement of brachial artery flow-mediated dilatation can be negatively correlated with the plasma vWF concentration and can sensitively reflect acute injury to vascular endothelial cells during CPB in cardiac surgery.
Role of Endothelial-Related Plasma Biomarkers in the Assessment of Endothelial Function
In the past, evaluation of endothelial function during CPB was based on plasma biomarkers. Other than this method, there is no better choice. However, many of the endothelial-related biomarkers are difficult and expensive to measure and currently are only used in clinical research settings. 8 Endothelial cells influence vascular tone by synthesis and release of a number of vasoactive substances. Nitric oxide is a main endothelium-derived vasorelaxing factor that is generated from L-arginine by the action of endothelial NO synthase in the presence of cofactors such as tetrahydrobiopterin. 17 The enzyme may be stimulated to increase NO synthesis by a variety of physiologic agonists, shear stress, and pharmacologic agents. 18, 19 As an endothelium-derived vasoconstricting factor, ET-1 is a 21-amino acid peptide that increases in patients with atherosclerosis, 20, 21 which is characterized by endothelial dysfunction. 22 von Willebrand factor is synthesized by and stored in endothelial cells. It appears to mediate platelet aggregation and adhesion. It is increased when endothelial cells are damaged, so vWF levels can be proposed as possible indicators of endothelial dysfunction. [23] [24] [25] [26] Compared with the low basal values in the patients in this study, the multifold increases in ET-1, NO, and vWF concentrations during CPB indicated that CPB can cause acute damage to the vascular endothelium.
Role of Sonographic Measurement of Brachial Artery Flow-Mediated Dilatation in the Assessment of Endothelial Function
Sonographic measurement of brachial artery flowmediated dilatation was first applied to evaluate endothelial function by Celermajer et al. 27 The rationale for this method is to increase the local shear stress by increasing local blood flow, stimulate the vascular endothelium to synthesize NO, and make the vascular smooth muscle relax. Studies have shown that both traditional and novel cardiovascular risk factors, including smoking, aging, hypercholesterolemia, hypertension, hyperglycemia, and a family history of premature atherosclerotic disease, are all associated with alterations in endothelial function, and sonography can effectively detect its change. 27, 28 In addition, sonographic evaluation of brachial artery endothelial function can be used as a window to evaluate systemic arterial endothelial function, and it has a good relationship with the coronary artery endothelium-dependent relaxing function, which can reflect coronary artery the endothelial function indirectly. 29, 30 Furthermore, the American College of Cardiology gave a good appraisal and worked out a set of standardized surgical techniques. 31 
Cardiopulmonary Bypass Causes Acute Endothelial Injury
The complex cardiac surgery, as well as the nonphysiologic CPB process, can cause serious damage to the vascular endothelium. We need to use a larger dose of anesthetics, compared with the other simple noncardiac operations, to reduce the body's stress response caused by the procedures of endotracheal intubation, surgery, and CPB. Several prior studies determined that anesthetics, such as etomidate, 32 fentanyl, 33 and sevoflurane, 34 can inhibit endothelium-dependent vasorelaxation. In the patients in this study, both vWF and NO started to change dramatically after endotracheal intubation, whereas ET-1 comparatively lagged behind. Meanwhile, the percentage of change in the sonographic measurement of brachial artery flowmediated dilatation was also significantly decreased after endotracheal intubation.
Furthermore, the CPB process may cause severe shear stresses to blood cells and activates several regulatory cascades, including the cytokine factor, the complement, and coagulation. 35, 36 Moreover, it is also important to remember that during cardiac operations, the interest in the metabolism of free radicals has been focused on the heart and lung because they are exposed during the ischemic and subsequent reperfusion phases. 37 Nevertheless, endothelial cells are extremely sensitive to these effects during CPB. Hence, it is well recognized that the whole-body inflammatory response induced by CPB is mainly responsible for endothelial dysfunction.
2 During CPB, we found that the plasma concentrations of the endothelial-related biomarkers climbed to their peaks, whereas the percentage of change in brachial artery flowmediated dilatation reached its nadir. Both results suggest that CPB had a serious impact on endothelium. In addition, among the 3 plasma biomarkers, the plasma vWF concentration seemed to be more sensitive for detecting early endothelial cell distress. There was a negative correlation between the plasma vWF concentration and the percentage of change in brachial artery flow-mediated dilatation, indicating that sonographic measurement of brachial artery flow-mediated dilatation can reflect the acute vascular endothelial cell injury early during CPB in cardiac surgery.
Due to the differences of elimination half-time and sensitivity values and the influence of intraoperative transfusion, the plasma concentrations of endothelialrelated biomarkers cannot accurately reflect endothelial function recovery, whereas sonographic measurement of brachial artery flow-mediated dilatation may better reflect such a change.
Limitations of the Research
This study had some limitations. First, because of the particularity of the cardiac surgery and the limitations of clinical trials, we could not use a more accurate method to evaluate endothelial function, such as coronary angiography, and plasma biomarkers are easily influenced by many factors, as mentioned above. However, our results still demonstrated that CPB caused endothelial damage. Second, the method of sonographic measurement of brachial artery flow-mediated dilatation has its limitations. 11 Due to the limitations of the conditions (lack of funds and the apparatus), we could not use the more advanced E-tracking techniques, 38 but we made a fixed support to reduce measuring variations caused by changes in the position of the ultrasound transducer. Finally, because of the clinical conditions, the use of vasoactive drugs, especially nitrate medications during the perioperative period, may have affected the sonographic measurements.
Conclusions
Although there were many outcomes in this study, the results still illustrate that CPB causes acute endothelial injuries, and application of sonographic measurement of brachial artery flow-mediated dilatation can reflect acute vascular endothelial cell injury at an earlier stage during cardiac surgery.
